Towards Healthcare
Latin America Cell and Gene Therapy Market to Grow at 31.61% CAGR till 2034

Latin America Cell and Gene Therapy Market Accelerates with AI Tech

Market insights predict, the Latin America cell and gene therapy industry is expected to grow from USD 3.72 billion in 2024 to USD 58 billion by 2034, driven by a CAGR of 31.61%. The rising prevalence of chronic and genetic diseases is expected to drive the growth of the market.

Content

  • Insight Code: 6287
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The Latin America cell and gene therapy market is valued at USD 5.25 billion in 2025 and is on track to reach USD 58 billion by 2034, witnessing a steady CAGR of 31.61% during the forecast span.

Brazil is leading the Latin America cell and gene therapy market due to its focus on personalized medicine, skilled workforce, and regulatory advancements.

Some key players include Novartis, Roche / Spark Therapeutics (Roche group), Gilead Sciences (Kite Pharma), Pfizer Inc., AstraZeneca, Sanofi, and Janssen (Johnson & Johnson) etc.

CAR-T (Chimeric Antigen Receptor T-cell) therapy is a type of gene therapy where a patient T-cells (a type of immune cell) are genetically modified to recognize and attack cancer cells. It is mainly used to treat blood cancers such as leukemia and lymphoma.

clinicaltrials.gov, WHO, JAMA, International Society for Cell & Gene Therapy, ASGCT- American Society of Gene & Cell Therapy, and ASH Latin American Training Program, etc.
Any Questions